Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/336497 
Erscheinungsjahr: 
2026
Schriftenreihe/Nr.: 
Discussion Papers No. 1032
Verlag: 
Statistics Norway, Research Department, Oslo
Zusammenfassung: 
This study evaluates the costs and benefits of alternative COVID-19 strategies for Norway, drawing on ex-post evidence from countries that pursued markedly different approaches. We argue that an elimination strategy-combining strict infection control with stringent border measures until a vaccine becomes available-delivers the greatest net benefits when a successful vaccine is expected within a short timeframe. Under vaccine uncertainty, both elimination and mitigation, the latter allowing gradual community spread, remain viable options. Norway adopted a suppression approach based on extensive TTIQ measures. Our findings suggest that this strategy was inferior compared to both elimination and mitigation. Finally, we compare ex-post assessments of costs and benefits with those emphasized in ex-ante evaluations, highlighting key discrepancies.
Schlagwörter: 
COVID-19
Strategies
Cost-benefit analysis
JEL: 
H51
I18
Dokumentart: 
Working Paper

Datei(en):
Datei
Größe
459.19 kB





Publikationen in EconStor sind urheberrechtlich geschützt.